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ABSTRACT
The effect of estrogens on sebaceous gland cell turnover time was measured in four
adult male volunteers administered 1 mg of ethinyl estradiol daily for six weeks. Two of
the subjects were continued on ethinyl estradiol for an additional six weeks during which
time 100 nig of methyl testosterone was administered orally per day together with the
estrogen. Biopsies were obtained from the non-hairy area of the cheek 40 minutes subse-
quent to the intradermal injection of 10 microcuries of tritiated thymidine. During the
administration of 1 mg of ethinyl estradiol, a decrease of approximately 50% in the labeling
index of the human sebaceous gland and its germinative layer was observed. When 100 mg
of methyl testosterone was administered concomitantly with the estrogen, the labeling
indices returned toward normal. The changes in the labeling indices were accompanied by
corresponding cbanges in sebum production.
It has been well established that human se-
baceous glands are influenced by sex steroids.
The administration of methyl testosterone to
prepuberal males has been shown to result in
both an increase in sebaceous gland size, as de-
termined by histologic examination of serial
sections, and an increase in glandular activity,
as measured by the gravimetric determination
of sebum production (1). The administration of
estrogen in high doses to adult males has been
shown to decrease both sebaceous gland size and
sebum production levels. However, smaller doses
of estrogen, which do not produce a histologi-
cally recognizable reduction in glandular size,
may still significantly reduce the secretion of
sebum (2). Such a descrepancy is somewhat
difficult to explain since the sebaceous gland is
a holocrine structure in which size would be ex-
pected to parallel secretory rate. The difference
may lie in the possibility that the gravimetric
determination of sebum production is a more
sensitive method than the estimation of glandu-
lar size by histologic observation. It also may
be due to alterations in cellular activity in the
sebaceous gland. For example, planimetric meas-
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urements of sebaceous gland size in rats have
shown that estrogens decrease gland size with-
out decreasing mitotie activity (3). In fact, it
was found in immature rats that estrogen ad-
ministration increased the incidence of mitosis.
In this study, we have investigated the effect
of estrogens on sebaceous gland cell turnover
utilizing the technic of tritiated thymidine nu-
clear tagging. We have also studied the effect on
cell turnover from the concomitant administra-
tion of estrogen and androgen. The turnover
studies have been compared with sebum produc-
tion levels determined gravimetrically.
MATERIALS AND METHODS
Four adult male volunteers were administered
1 mg of ethinyl estradiol orally per day for six
weeks. During an initial control period, and at the
end of six weeks of ethinyl estradiol administra-
tion, a 4 mm punch biopsy was obtained from the
non-hairy area of the cheek, 40 minutes subsequent
to the intradermal injection of 10 zc of tritiated
thymidine (6.7C/mM; obtained from New Eng-
land Nuclear Corporation, Boston, Mass.) accord-
ing to the method described by Epstein and Ep-
stein (4). Two of the subjects were continued on
1 mg of ethinyl estradiol orally per day for an
additional six weeks during which time 100 mg of
methyl testosterone daily was administered orally
together with the estrogen. Additional biopsies
were obtained from these two subjects at the
end of the experiment. Radioautography was per-
formed on serial sections of each specimen utiliz-
ing Kodak NTB-2 photographic emulsion. The
tritiated thymidine labeling index (the number of
labeled nuclei per 1000 total nuclei) was deter-
mined for both the germinative layer and for the
whole gland. A minimum of 1500 germinative cells
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and 5200 total gland cells were counted for each
subject. Sebum production was measured approxi-
mately once weekly according to the method of
Strauss and Pochi (5). The values for sebum
production given in this paper represent a mean
of the last three values during each observation
period.
RESULrS
The results are given in Table I. Tests for
statistical significance were determined by the
method of paired comparisons. The labeling in-
dex, calculated both for the germinative layer
and for the whole gland, is shown for each sub-
ject during the control period, during the period
of ethinyl estradiol administration, and during
the period of ethinyl estradiol plus methyl tes-
tosterone administration for the two subjects so
treated. During estrogen administration, the
labeling index as determined for both the whole
gland and the germinative layer fell to approxi-
mately 50% of the respective control values.
When methyl testosterone was administered
with ethinyl estradiol, the labeling indices re-
turned toward the control level. The decrease of
about 50% in the labeling indices during estrogen
administration was accompanied by a decrease
in sebum production which varied from 30% to
58% in the four subjects. When methyl testos-
terone and ethinyl estradiol were administered
together, sebum production returned toward
the control level, roughly paralleling the changes
in the labeling indices.
Histologic examination showed no recognizable
decrease in gland size in any of the four subjects
during estrogen administration.
DISCUSSION
The daily dose of 1 mg of ethinyl estradiol
was chosen because this level had been previ-
uusly shown to produce a consistent decrease in
sebum production in most adult males without
a detectable histologic decrease in gland size.
The studies reported here reveal that this dose
also produces a significant decrease in the label-
ing indices of the sebaceous glands.
The turnover time of a constantly renewing
population of cells such as the sebaceous gland
can be calculated if the DNA synthesis time is
known and if the labeling index is determined
by direct counting (5, 7). The relationship be-
tween turnover time and labeling index can be
expressed by the following formula:
Where:
T is the turnover time
t, is the DNA synthesis time and
ne/N is the labeling index, that is, the number
of labeled nuclei per total nuclei present
Therefore, as the labeling index decreases, the
value for the turnover time increases. If the
DNA synthesis time of the proliferating cells of
the sebaceous glands is not altered by the ad-
ministration of estrogen, then the observed de-
crease in the labeling index would be indicative
of an increase in the turnover time.
Ebling (3) utilized the colehicine arrest
method to study the effect of estrogen on the
proliferation of rat sebaeeous glands. From his
studies it appeared that exogenous estrogen de-
creased the turnover time of the sebaeeous
glands in rats. However, both Ebling's study
and ours have not taken into account the possi-
bility that estrogens may alter various phases
of the cell cycle. For example, Ebling's finding
TABLE I
Effect of hormonal administration on labeling
indices of the germinative layer and of the whole
sebaceous gland, and on sebum production
Subject
Control1 Ethinyl estradiol*
Gerniin-
ative
layer
labeling
index
75.4
44.4t
Whole
gland
labeling
42.3
12.8
Sebum
produc-
tion
(mg/ 10
cm2/3 lir)
4.23
2.92
Control2. Ethinyl estradiol
69.8
46.St
28.0
13.5
2.20
1.56
Control
Ethinyl estradiol
Ethinyl estradiol plus
methyl testosterone
79.6
41.4t
73.1
35.2
13.4
20.3
1.69
0.71t
1.29
Control
Ethinyl estradiol
Ethinyl estradiol plus
methyl testosterone
60.8
35.7t
59.3
33.8
17.6
30.0
3.74
1.60
2.05
* See text for dosages.
<.01.
P < .05.
3.
4.
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of an increased incidence of mitoses in immature
rats could result from a prolongation of mitosis
under the influence of estrogens. Our findings of
a decreased thymidine labeling index could re-
sult from a shortening of DNA synthesis time.
This study showed a correlation between la-
beling indices and sebum production levels. Such
a correlation indicates that the decreased sebum
production levels resulted from effects on the
gland itself, either directly or indirectly, and not
from other factors such as impeded delivery of
sebum to the skin surface, etc. With the adminis-
tration of estrogen, there was a consistent de-
crease in the labeling index to about 50% of the
control value. A corresponding but more vari-
able decrease was found in the sebum produc-
tion level. These values also correlated well when
testosterone was administered concomitantly
with estrogen, both showing a return toward the
control level. Furthermore, these results show
that estrogens alter the cellular activity of the
sebaceous glands even though visible changes in
gland size were not detectable. Human sebace-
ous glands do not readily lend themselves to
accurate planimetrie measurements because of
the marked variability in size between glands
and the irregular shape of the individual glandu-
lar acini. However, if accurate planimetric stud-
ies were feasible, changes in gland size might
have been detectable.
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